<?xml version="1.0" encoding="UTF-8"?>
<p>Six compounds were selected by the NCI, according to NCI’s DTP selection guidelines
 <xref rid="CIT0057" ref-type="bibr">
  <sup>57</sup>
 </xref>, for evaluation of their anticancer activity at a single-dose of 10 µM against 60 human tumours cell lines. The compounds’ screening findings are summarised in 
 <xref rid="t0001" ref-type="table">Table 1</xref>. Data analysis resulting from the primary assay showed that chalcone derivatives 
 <bold>Vd</bold>, 
 <bold>Ve</bold>, and 
 <bold>Vf</bold> showed moderate to good inhibitory activity mainly against leukaemia and colon cancer cell lines.
</p>
